Greenleaf Trust Decreases Stake in DuPont de Nemours, Inc. $DD

Greenleaf Trust cut its position in shares of DuPont de Nemours, Inc. (NYSE:DD) by 71.8% in the second quarter, Holdings Channel.com reports. The institutional investor owned 5,672 shares of the basic materials company’s stock after selling 14,453 shares during the period. Greenleaf Trust’s holdings in DuPont de Nemours were worth $769,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Palisade Asset Management LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth approximately $26,000. Imprint Wealth LLC bought a new position in shares of DuPont de Nemours during the 3rd quarter valued at approximately $27,000. Basepoint Wealth LLC purchased a new position in shares of DuPont de Nemours in the fourth quarter valued at $28,000. Nalls Sherbakoff Group LLC purchased a new position in shares of DuPont de Nemours in the fourth quarter valued at $29,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in DuPont de Nemours in the third quarter worth $30,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

DuPont de Nemours Stock Performance

NYSE:DD opened at $132.07 on Wednesday. The firm has a market capitalization of $17.83 billion, a PE ratio of 293.55, a PEG ratio of 1.23 and a beta of 1.06. The stock’s fifty day moving average is $138.71 and its 200 day moving average is $141.01. DuPont de Nemours, Inc. has a fifty-two week low of $92.49 and a fifty-two week high of $157.98. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.43.

DuPont de Nemours (NYSE:DD) last posted its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period in the previous year, the firm earned $1.12 earnings per share. DuPont de Nemours’s quarterly revenue was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. On average, sell-side analysts anticipate that DuPont de Nemours, Inc. will post 7.27 earnings per share for the current year.

DuPont de Nemours Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.8%. DuPont de Nemours’s payout ratio is currently 533.33%.

Analyst Ratings Changes

DD has been the topic of a number of recent research reports. Zacks Research downgraded shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. Citigroup lifted their price objective on shares of DuPont de Nemours from $168.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. UBS Group boosted their target price on shares of DuPont de Nemours from $175.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. JPMorgan Chase & Co. increased their price target on shares of DuPont de Nemours from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Monday, August 10th. Finally, BMO Capital Markets lifted their price target on DuPont de Nemours from $75.30 to $180.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Twelve equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $166.60.

DuPont de Nemours Profile

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.